Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Tab 1

Research Article

Safety and Efficacy of the C-117 Formula for Vulnerable Carotid Artery Plaques (Spchim): A Randomized Double-Blind Controlled Pilot Study

Table 1

Study inclusion and exclusion criteria.

Inclusion criteria

1Meet the diagnostic criteria of carotid artery atherosclerosis
2Ultrasound of carotid artery atherosclerotic plaque specifies it as an
unstable plaque (including malakoplakia and mixed plaque);
3Can persist on long-term medication
4Older than 18 and under 80 years old
5Meet the diagnostic criteria of hyperlipidaemia: Fasting serum total cholesterol ≥ 5.72 mmol/L or triglycerides ≥ 1.70 mmol/L or low density lipoprotein ≥ 1.8 mmol/L;

Exclusion Criteria:

1mRS rating higher than or equal to 3 before joining the trial group;
2Carotid artery stenosis higher than or equal to 50%;
3Confirmed or suspected vasculitis;
4Infection, tumour or insufficient heart, liver and kidney functions
(renal function higher than twice the upper limit in normal limits,
HYHA heart function grading higher than or equal to level 2);
5Acute myocardial infarction and unstable angina pectoris;
6Acute cerebral arterial thrombosis;
7Severe stenosis or occlusion of distal intracranial vessels;
8Pregnant women or lactating mothers;
9Known history of allergy to the trial drugs.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.